Corvus Pharmaceuticals Announces Partner Angel Pharmaceutica

BURLINGAME, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that its partner in China, Angel Pharmaceuticals

Related Keywords

China , Yuqin , Xizang , United States , Peking , Beijing , Chinese , America , American , Angel Pharma , Leiv Lea , Richarda Miller , Angel Pharmaceuticals Ltd , Exchange Commission On , Corvus Pharmaceuticals , Angel Pharmaceuticals , Lymphoma Department At Peking University Cancer Hospital , Lymphoma Alliance , Corvus Pharmaceuticals Inc , Exchange Commission , American Society Of Hematology , Company Quarterly Report On Form , Chinese Society Of Clinical Oncology , Angel Pharma Phase , Song Yuqin , Chinese Society , Clinical Oncology , Anti Lymphoma Alliance , Deputy Director , Lymphoma Department , Peking University Cancer Hospital , American Society , Looking Statements This , Angel Pharmaceutical , Quarterly Report , Sheryl Seapy Real Chemistry , Money , Ational ,